BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33308266)

  • 1. Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravis.
    Europa TA; Nel M; Heckmann JM
    Orphanet J Rare Dis; 2020 Dec; 15(1):346. PubMed ID: 33308266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravis.
    Nel M; Prince S; Heckmann JM
    Orphanet J Rare Dis; 2019 Jan; 14(1):24. PubMed ID: 30696470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases.
    Europa TA; Nel M; Lebeko MR; Heckmann JM
    IBRO Neurosci Rep; 2022 Jun; 12():297-302. PubMed ID: 35746973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Whole Genome Sequencing in an African Subphenotype of Myasthenia Gravis to Generate a Pathogenetic Hypothesis.
    Nel M; Mulder N; Europa TA; Heckmann JM
    Front Genet; 2019; 10():136. PubMed ID: 30881381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique subphenotype of myasthenia gravis.
    Heckmann JM; Nel M
    Ann N Y Acad Sci; 2018 Jan; 1412(1):14-20. PubMed ID: 28984362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing identifies targets in the treatment-resistant ophthalmoplegic subphenotype of myasthenia gravis.
    Nel M; Jalali Sefid Dashti M; Gamieldien J; Heckmann JM
    Neuromuscul Disord; 2017 Sep; 27(9):816-825. PubMed ID: 28673556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular muscles.
    Europa TA; Nel M; Heckmann JM
    Neuromuscul Disord; 2019 May; 29(5):381-387. PubMed ID: 31029532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The African-387 C>T TGFB1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis.
    Nel M; Buys JM; Rautenbach R; Mowla S; Prince S; Heckmann JM
    J Hum Genet; 2016 Apr; 61(4):307-16. PubMed ID: 26632886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraocular Muscle Findings in Myasthenia Gravis Associated Treatment-Resistant Ophthalmoplegia.
    Rautenbach RM; Pillay K; Murray ADN; Heckmann JM
    J Neuroophthalmol; 2017 Dec; 37(4):414-417. PubMed ID: 28742638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of the unique human extraocular muscle allotype by expression profiling.
    Fischer MD; Budak MT; Bakay M; Gorospe JR; Kjellgren D; Pedrosa-Domellöf F; Hoffman EP; Khurana TS
    Physiol Genomics; 2005 Aug; 22(3):283-91. PubMed ID: 15855387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbital magnetic resonance imaging of extraocular muscles in chronic progressive external ophthalmoplegia: specific diagnostic findings.
    Ortube MC; Bhola R; Demer JL
    J AAPOS; 2006 Oct; 10(5):414-8. PubMed ID: 17070475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders.
    Keene KR; Notting IC; Verschuuren JJGM; Voermans N; de Keizer ROB; Beenakker JM; Tannemaat MR; Kan HE
    J Neuromuscul Dis; 2023; 10(5):869-883. PubMed ID: 37182896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis.
    Velonakis G; Papadopoulos VE; Karavasilis E; Filippiadis DK; Zouvelou V
    Neuroradiology; 2021 Sep; 63(9):1531-1538. PubMed ID: 34232334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraocular muscle responses to orbital cooling (ice test) for ocular myasthenia gravis diagnosis.
    Ellis FD; Hoyt CS; Ellis FJ; Jeffery AR; Sondhi N
    J AAPOS; 2000 Oct; 4(5):271-81. PubMed ID: 11040476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in gene expression between strabismic and normal human extraocular muscles.
    Altick AL; Feng CY; Schlauch K; Johnson LA; von Bartheld CS
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5168-77. PubMed ID: 22786898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraocular muscle characteristics related to myasthenia gravis susceptibility.
    Liu R; Xu H; Wang G; Li J; Gou L; Zhang L; Miao J; Li Z
    PLoS One; 2013; 8(2):e55611. PubMed ID: 23409007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A.
    Demer JL; Clark RA; Engle EC
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):530-9. PubMed ID: 15671279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders.
    Yu Wai Man CY; Chinnery PF; Griffiths PG
    Neuromuscul Disord; 2005 Jan; 15(1):17-23. PubMed ID: 15639116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
    McCreery KM; Hussein MA; Lee AG; Paysse EA; Chandran R; Coats DK
    Binocul Vis Strabismus Q; 2002; 17(3):181-6. PubMed ID: 12171588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.